Rak dojke
Literatura Glavna stranica
 Literatura (povijest raka dojke) Nazad

1. Duančić V. Osnove histologije čovjeka. IX izdanje. Beograd, Zagreb: Medicinska knjiga; 1986. p. 315-20.

2. Cotran R S, Kumar V, Robbins S L. The Breast. In: Cotran R S, Kumar V, Robbins S L. Robins Pathologic Basis of Disease. 4th ed. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: W.B. Saunders Company; 1989. p. 1181-204.

3. Sadler T W. Langman's Medical Embryology. Fifth ed. Baltimore, London, Sydney: Williams & Wilkins; 1985. p. 331-3.

4. Margaritoni M. Rak dojke. 1. izd. Zagreb: Školska knjiga; 1993.

5. Sperof L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. Baltimore: Wiliams & Wilkins; 1994. p. 547-82.

6. Duančić V. Osnove embriologije čovjeka. Zagreb: Medicinska knjiga; 1983. p. 177-8.

7. Greenhill JP. Opstetricija. Beograd Zagreb: Medicinska knjiga; 1963. p. 101-5.

8. Nikolić V. Dojka, mamma. U: Krmpotić-Nemanić J. Anatomija čovjeka. Zagreb: Jumena; 1992. p. 524-8.

9. Netter FH. The Ciba collection of medical illustrations. Volume 2. Reproductive system. New York: Ciba; 1970. p. 243-266.

10. Oaza AM, Tannock IF. Clinical Relevance of Breast Cancer Biology. Hematology/Oncology Clinics of North America 1994;8:1:1-14.

11. Egan RL. Breast Imaging. Third Edition. Rockville, Maryland: Aspen; 1984. p. 21-9.

12. Harper P. Ultrasound Mammography. Baltimore: University Park Press; 1985.

13. Junqueira LC, Carneiro J. Basic Histology. 4 th ed. Los Altos California: Lange Medical Publications; 198. p. 489-93.

14. Maričić Ž, Nola P, Rudan N. Dojka. U: Piljac G. Rak klinička onkologija. Čakovec: TIZ Zrinski; 1977. p. 499-522.

15. Guyton AC. Medicinska fiziologija. Beograd, Zagreb: Medicinska knjiga; 1986. p. 1376-97.

16. Disaia PJ, Creasman WT. Clinical Gynecologic Oncology. St. Louis: Mosby Year Book; 1993. p. 467-516.

17. Berkow R, editor. The Merck Manual. Sixteenth Edition. Rahway, N J: Merck & Co; 1992.

18. Glesinger L. Medicina kroz vjekove. Zagreb: Zora; 1954.

19. Vrdoljak M, Tomljanović I, Knežević F, Eljuga Lj, Ramljak V, Vrdoljak D, Eljuga D. Dijagnostička vrijednost ultrazvuka u bolestima dojke. Borba protiv raka 1993; 24:47-9.

20. Greenall M J. Cancer of the breast. In: Oxford textbook of Surgery, N York: Oxford University Press; 1994.

21. Donegan WL, Redlich PN. Breast cancer in men. Surg Clin North Am 1996;76:2:343-63.

22. Strnad M. Trends of Cancer Incidence and Mortality in Croatia. Libri Oncol 1994; 23:91-6.


23. Parkin DM, Muir CS, Whelan SL. Cancer incidence in five continents, vol 6. IARC Scientific Publications no. 120. Lyon, IARC, 1992.

24. Weiss S E, Tartter P I, Ahmed S, Brower S T, Brusco C, Bossolt K, Amberson J B, Bratton J. Ethnic Differences in Risk and Prognostic Factors for Breast Cancer. Cancer 1995;76:268-74.

25. Garfinkel L, Boring CC, Heath Jr. CW. Changing Trends. Cancer 1994; 1 Suppl 74:222-7.

26. Moormeier J. Breast cancer in black woman. Ann Intern Med 1996;124:10:897-905.

27. Zhang S, Folsom A, Sellers T A, Kushi L, Potter J D. Better Breast Cancer Survival for Postmenopausal Woman Who Are Less Overweight and Eat Less Fat. Cancer 1995;76:275-83.

28. Henderson I C, Harris J R, Kinne D W, Hellman S. Cancer of the Breast. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer Principles & Practice of Oncology. Philadefphia, Grand Rapids New York, St. Louis, San Francisco, London, Sydney, Tokyo: J. B. Lippincott Company; 1989. p. 1197-268.

29. Anelli A, Anelli TFM, Youngson B, Rosen P, Borgen PI. Mutations of the p53 Gene in Male Breast Cancer. Cancer 1995; 75:2233-8.

30. Thompson WD. Genetic Epidemiology of Breast Cancer. Cancer 1994; 1 Suppl 74:279-87.

31. Kinoshita T, Ueda M, Enomoto K, Ikeda T, Kikuchi K, Ishii S, Kitajima M. Comparation of p53 Gene Abnormalities in Bilateral and Unilateral Breast Cancer. Cancer 1995; 76:2504-9.


32. FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Arrieto SS, Finkelstein DM, Beer-Romero P, Englert C i sur. Germ - line BRCA1 mutations in Jewish and non Jewish woman with early onset breast cancer. N Engl J Med 1996; 334:3:143-9.

33. Hayes F. When Is a Tumor Marker Ready for Prime Time? In: Perry M C, editor. American Society of Clinical Oncology. Washington, Boston, San Antonio: American Society of Clinical Oncology; 1997. p. 206-12.

34. Garber J. Breast Cancer Markers: Genetic Markers of Breast Cancer Predisposition. In: Perry M C, editor. Washington, Boston, San Antonio: American Society of Clinical Oncology; 1997. p. 213-6.

35. Ravdin P M. Prognostic Factors in Breast Cancer. In: Perry M C, editor. Washington, Boston, San Antonio: American Society of Clinical Oncology; 1997. p. 217-27.

36. Hayes D. Serum (Circulating) Tumor Markers for Breast Cancer. In: Perry M C, editor. Washington, Boston, San Antonio: American Society of Clinical Oncology; 1997. p. 228-33.

37. Cole DE, Gallinger S, McCready DR, Rosen B, Engel J, Malkin D. Genetic counselling and testing for suspectibility to breast, ovarian and colon cancer: where are we today? Can Med Assoc J 1996;154:2: 149-55.

38. Lancaster JM, Wiseman RW, Berchuck A. An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene. Obstet Gynecol 1996;87:2: 306-9.

39. Radford DM, Zehnbauer BA. Inherited breast cancer. Surg Clin North Am 1996; 76:2:205:20.


40. Langston AA, Malone KE,Thompson JD,Daling JR, Ostrander EA. BRCA1 mutations in a population - based sample of young women with breast cancer. N Engl J Med 1996; 334:3:137- 42.

41. Kuller LH. The etiology of breast cancer from epidemiology to prevention. Public Health Rev 1995; 23:2:157-213.

42. Nason FG, Nelson BE. Estrogen and progesteron in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement. Obstet Gynecol Clin North Am 1994; 21:2:245-70.

43. Bagga D, Ashley J M, Geffrey SP, Wang HJ, Barnard RJ, Korenman S, Heber D. Effects of a Very Low Fat, High Fiber Diet on Serum Hormones and Menstrual Function. Cancer 1995;76:2491-6.

44. Kumar N B, Lyman G H, Allen K, Cox C E, Schapira D V. Timing of Weight Gain and Breast Cancer Risk. Cancer 1995;76:243-9.

45. Frisch R, Gotz-Welbergen A, McArthur J. Delayed menarche and amenorrhea of college athlethes in relatio to age at onset of training. JAMA 1981;246:1559.

46. Rookus M A, van Leeuwen F E. Oral contraceptives and risk of breast cancer in women aged 20-54 years. The Lancet 1994; 344:844-51.

47. Colditz G A, Hanminson S E, Hunter D J, Willett W C, Manson J E, Stampfer M J, Hennekens C, Rosner B, Speizer F E. The use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women. N Engl J Med 1995; 332: 1589-93.

48. Davidson N E. Hormone - replacement therapy - Breast versus Heart versus Bone. N Engl J Med 1995; 332:1638-9.


49. Mann R D, editor. Hormone Replacement Therapy and Breast Cancer Risk. 1 th ed. Lancs, New Jersey: ,The Parthenon Publishing Group; 1992. p. 169-70.

50. Newell GR. Advising Patients About Benefits and Cancer Risks of Taking Hormones. Primary Care & Cancer 1991;11:6:23-5.

51. McMhann CF. Pitfalls and Problems in Breast Palpitation. Primary Care & Cancer 1991;11:6:15-21.

52. Speroff L. Postmenopausal hormone therapy and breast cancer. Obstet Gynecol 1996;2 Suppl 87:44-54.

53. Page DL. The woman at high risk for breast cancer. Importance of hyperplasia. Surg Clin North Am 1996;76:2:221:30.

54. Beral V. Breast cancer mortality in England and Wales, 1950-93. Lancet 1995; 345 : 1642-43. 

55. Another look at the pill and breast cancer (editorial). Lancet 1985;2:985-7.

56. McPherson K, Neil A, Vessey M. Oral contraceptives and breast cancer. (Letter) Lancet 1983;2:1414.

57. Siiteri P, Hammond G, Nishker J. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike M, Siiteri P, Welsh C. Hormones and breast cancer. NY: Cold Spring Harbor Laboratories; 1981.

58. de Waard F, Cornelis J, Aoki K. Breast cancer incidence accoding to weight and height in two cities of the Netherlands and in Aichi Prefecture, Japan. Cancer 1977;40:1269.

59. Schapira D V, Clarc R A, Wolff P A, Jarrett A R, Kumar N B, Aziz N M. Visceral Obesity and Breast Cancer Risk. Cancer 1994;74 :632 - 9.
60. Byers T. Nutritional Risk Factors for Breast Cancer. Cancer 1994; 1 Suppl 74:288-95.

61. Hunter DJ, Spiegelman D, Adami HO, Beeson L, Brandt PA, Folsom AR, Fraser GE, Goldbohm RA, Graham S, Howe GR i sur. Cohort studies of fat intake and risk of breast cancer a pooled analysis. N Engl J Med 1996;334:6:356-61.

62. Vatten L J, Kvinnsland S. Cigarette Smoking and Risk of Breast Cancer: a Prospective Study of 24329 Norwegian Women. Eur J Cancer 1990; 26: 830-3.

63. Colditz G A. Epidemiology of Breast Cancer. Cancer 1993;71 Suppl 71:1480-9.

64. Henderson B I. Breast Cancer. In: Isselbacher K J, Braunwald E, Wilson J D, Martin J B, Fauci A S, Kasper D. Harrison's principles of internal medicine. New York: McGraw-Hill; 1994. p. 1840-50. 

65. Harris JR, Lippman ME, Morrow M, Hellman S. Disease of the Breast. Philadelphia - New York: Lippincott - Raven; 1996. p. 159-355.

66. Petrinec Z, Huljev D. Selenium Levels in Blood Serum of Females with Breast Cancer. Libri Oncol 1994;23:211-3.

67. Hunter D J, Manson J E, Colditz G A. A prospective study of consumption of vitamins C, E and A and breast cancer risk. N Engl J Med 1993;329:234.

68. Martin-Moreno JM, Willett WC, Gorgojo L. Dietary fat, olive oil intake and breast cancer risk. Int J Cancer 1994;58:774.

69. Giuliano A E Breast Cancer In: Berek J S, Adashi E Y, Hillard P A. Novak's Gynecology. 12th ed. Baltimore, London, Paris: Williams & Wilkins; 1996:1283-302.


70. Brinton A, Devesa SS. Environmental Factors. In: Harris JR, Lippman ME, Morrow M, Hellman S. Disease of the Breast. Philadelphia - New York: Lippincott - Raven; 1996. p. 159-68.

71. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB. Migration Patterns and Breast Cancer Risk in Asian - American Women. J Natl Cancer Inst 1993; 85:1819-27.

72. Halbreich U, Shen J, Panaro V. Are chronic psychiatric patients at increased risk for developing breast cancer? Am J Psychiatry 1996;153:4:559-60.

73. Rosen PP, Oberman HA. Atlas of Tumor Pathology. Tumors of the Mammary Gland.Washington: Armed Forces Institute of Pathology; 1993. p. 7-10.

74. McDivitt RD, Stewart FW, Berg JW: Tumors of the Breast. Washington: Armed Forces Institute of Patology; 1968.

75. Sharkey FE, Allred DC, Valente PT. Breast In: Kissane JM, editor. Anderson's Pathology. Ninth Edition. St. Louis, Baltimore, Philadelphia, Toronto: Mosby; 1990. p. 2354-85.

76. World Health Organization: Histologic typing of breast tumors. Washington: The Institute; 1982.

77. Curran RC. Atlas histopatologije. Ljubljana: Cankarjeva založba; 1985. p. 106 -19.

78. McKhann C. Pitfalls and Problems in Breast Palpation. Primary Care and Cancer 1991;6:15-21.

79. Porrath S. A Multimodality Approach to Breast Imaging. 1th ed. Rockville, Maryland: Aspen; 1986.
80. Gordon P B, Goldenberg S L. Malignant Breast Masses Detected Only by Ultrasound. Cancer 1995;76:626-30.

81. Vlaisavljević V. Bolesti dojke: dijagnostika i detekcija. In: Kurjak A. Ginekologija i perinatologija I. II izdanje. Varaždinske Toplice: Golden Time; 1995. p. 511-36.

82. Mihelčić Z, Krajina Z, Budišić Z, Eljuga Lj, Podolski P. Mamografija kao dijagnostička metoda u ranom otkrivanju bolesti dojke u žena - prednosti, mane i rizici. Borba protiv raka 1993;24:1:39-42.

83. Ezo MG, Hagen Ansert SL. Breast. In: Hagen - Ansert SL. Textbook of diagnostic ultrasonography. Third ed. St. Louis, Baltimore, Philadelphia, Toronto: Mosby; 1989. p. 338-54.

84. Hrgović Z, Habibović S, Lung D. Dinamika tumorskih markera kod različitih TNM stadija dojke. Gynaecol Perinatol 1995;4,2:59-63.

85. Osbrne M P, Bradlow H L, Wong G Y C, Telang N T. Upregulation of Estradiol C16-hydroxylation in Human Breast Tissue: a Potential Biomarker of Breast Cancer Risk. J Natl Cancer Inst 1993; 85:1917-20.

86. American Joint Committee on Cancer. Manual for Staging of Cancer. 3 th Edition. Philadelphia, London, Mexico, New York, St. Louis, Sao Paulo, Sydney: J. B. Lippincott Company; 1988. p. 145-50.

87. Wilson J F. The Breast. In:Moss W T, Cox J D, editors. Radiation Oncology. 6 th Edition. St. Louis, Baltimore, Philadelphia, Toronto: Mosby; 1989. p. 312-37.

88. Čović D, Krajina Z, Bišćan M, Šamija M. U: Šamija M, Krajina Z, Purišić A, urednici. Radioterapija, Zagreb: Nakladni zavod Globus; 1996. p. 129-57.


89. Čović D, Krajina Z, Bišćan M, Šamija M. Dojka. U: Turić M, Kolarić K, Eljuga D, urednici. Klinička onkologija, Zagreb: Nakladni zavod Globus; 1996. p. 587-628.

90. Medicinska enciklopedija. Drugi dopunski svezak. Zagreb: Jugoslavenski leksikografski zavod "Miroslav Krleža"; 1986. Mlinarić I. Novija dostignuća u liječenju raka dojke; p. 119-20. 

91. Wood WC. Progress from Clinical Trials on Breast Cancer. Cancer 1994; 74:2606-9.

92. Byrne C, Smart C R, Chu K C, Hartmann H. Survival Advantage Differences by Age. Cancer 1994; 1 Suppl 74:301-10.

93. Fleming I D, Fleming M D. Breast Cancer in Elderly Woman. Cancer 1994; Suppl 74:2160-4.

94. Gordon JD, Rydfords JT, Druzin ML, Tadir Y. Obstetrics Gynecology Infertility. Fourth ed. Menlo Park: Scrub Hill Press; 1995. p. 105-11.

95. Hunter DJ, Willett WC. Dietary Factors. In: Harris JR, Lippman ME, Morrow M, Hellman S. Disease of the Breast. Philadelphia - New York: Lippincott - Raven; 1996. p. 201-13.

96. Ballard-Barbash R, Swanson CA. Body weight: estimation of risk for breast and endometrial cancers. Am J Clin Nutr 1996;63:3 Suppl:437-41.

97. Mansour EG, Ravdin PM, Dressler L. Prognostic Factors in Early Breast Carcinoma. Cancer 1994; 1 Suppl 74:381-400.

98. Nair K, Sankaranarayanan R, Nair S, Amma NS Varghese C, Padmakumari G, Cherian T. Overall Survival from Breast Cancer in Kerala, India, in Relation to Menstrual, Reproductive, and Clinical Factors. Cancer 1993;71:1791-6.
99. Rudan I, Škorić T, Rudan N. Breast Cancer Prognosis. I. Prognostic Factors in Patients with node - negative (N0) Breast Cancer. Acta med Croatica 1994; 48:159-63.

100. Rudan I, Škorić T, Rudan N. Breast Cancer Prognosis. II. Prognostic Factors in Patients with node - negative (N1-3) Breast Cancer. Acta med Croatica 1994; 48:165-70.

101. Clayton F, Hopkins CL. Pathologic Correlates of Prognosis in Lymph Node - Positive Breast Carcinomas. Cancer 1993; 71:1780-90.

102. Rudan I, Škorić T, Rudan N. Breast Cancer Prognosis. III. Prognostic Factors in Patients with distant metastases (M1) at the time of diagnosis. Acta med Croatica 1994; 48:171-4.

103. Nola N, Šeparović V, Šarčević B, Graf D, Petrinec Z, Mateša N, Krušlin B. Odnos između stupnja histološke diferenciranosti i hormonskih receptora kod raka dojke. Liječ Vjesn 1995;117:117-20.

104. Querzoli P, Ferretti S, Albonico G, Magrio E, Scapoli D, Indelli M, Nenci I. Application of Quantitative Analysis to Biologic Profile Evaluation in Breast Cancer. Cancer 1995;76:2510-7.

105. Bonsing BA, Beerman H, Kuipers Dijkshoorn N, Fleuren GJ, Cornelisse CJ. High Levels of DNA Index Heterogeneity in Advanced Breast Carcinomas. Cancer 1993;71:382-91.

106. Prpić I, Unušić J, urednici. Peti znanstveni sastanak bolesti dojke. 1995 11 listopada; Zagreb: Zbornik; 1995.

107. Djuric Z, Heilbrun L K, Simon M S, Smith D, Luongo D A, LoRusso P M, Martino S. Levels of 5-hydroxymethyl-2'-deoxyuridine in DNA from blood as a marker of breast cancer. Cancer 1996;77:4:691-6.
108. Jančar B. Breast cancer screening. Radiol Oncol 1993; 27:232-5.

109. Eddy DM, Hasselblad V, McGivney W. The value of mammograph screening in woman under age 50 years. JAMA 1988;259:1512-9.

110. Mettlin C. The Relationship of Breast Cancer Epidemiology to Screening Recommendations. Cancer 1994; 1 Suppl 74:228-30.

111. Kraljević Lj, Perković Z, Štambuk I. Probir i minimalni rak dojke. Borba protiv raka 1995;1:40-2.

112. Holden C. Cancer and the mind. How are they conncted. Science 1978; 200:1363-6.

113. Lermar S. Krebs und Psyche. Munchen: Causa Verlag;1982.

114. LeShan L. An emotional life history pattern associated with neoplastic disease. Ann N Y Acad Sci 1966;125:780-4.

115. Southan C M. Emotions, immunology and cancer. Ann N Y Acad Sci 1969;164:473-7.

116. Lecompte D. Revue critique de la litterature les facteures psychogenetiques des affections cancereuses. Acta psychiat Belg 1979;79:144-7.

117. Lesić Ž. Rak i duševni život. Zagreb: Grafički zavod Hrvatske; 1985.

118. Cividini Stranić E. Psihosomatika U: Blažević D, Cividini Stranić E, Beck Dvoržak M. Medicinska psihologija. Zagreb: Jumena; 1984. p. 151-62.

119. Levitan L J, Levitan H, Levitan M. The incidence of cancer in psychiatric patients. The Mount Sinai J of Med 1980;47:62-7.

120. Siegrist J. Die Bedeutung von Lebensereignissen fűr die Entstehung kőrperlicher und psychosomatischer Erkrankungen. Nervenarzt 1980;51:313-9.

121. Riley V, Spackman D. Modifying effects of benign virus on the malignant process and the role of physiological stress on tumor incidence. Nat inst of Health Bethesda 1974;9:319-23.

122. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 1981;212:1100-4.

123. Greene W A. The psychological setting of the development of leukemia and lymphoma. Ann N Y Acad Sci 1966;125:794-8.

124. Shekelle R B, Raynor W J, Ostfeld A M, Garron D C, Bieliauskas L A, Liu S C, Malize C, Paul O. Psychological depression and 17-year of death from cancer. Psychol Med 1981;43:117-20.

125. Clarck G M. Prognostic and predictive factor. In: Harris JR, Lippman ME, Morrow M, Hellman S. Disease of the Breast. Philadelphia - New York: Lippincott - Raven; 1996. p. 441-85.

Nazad